Earnings Call · Q3 FY2021·2021-11-04

Q3 21EPS -22.56%·Rev n/aQ2 21EPS -10.00%·Rev n/aQ1 21EPS +28.16%·Rev n/aQ4 20EPS -48.39%·Rev n/a⚠ consensus missing

Natera, Inc. NTRA

Michael Brophy — Chief Financial Officer

Steve Chapman — Chief Executive Officer

Solomon Moshkevich — General Manager of Oncology

Tejas Savant — Analyst

−1.1%1d on move date−1.6% vs SPY3d+4.4%5d−4.4%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NTRA calls or request research access.

More NTRA calls Browse calls Request research access